Mytesi
My Prescription
Payment
Select pharmacy
$2,804.46
$30.00 due at pharmacy
$2,804.46 - $30.00 = $2,774.46
$2,774.46 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
AlbertsonsPowered by$2,804.46
Print or send this coupon to your phone
AlbertsonsPowered byAbout Mytesi
Drug Details
Crofelemer, marketed under the brand name Mytesi, is specifically designed to alleviate diarrhea in adults who are undergoing treatment with HIV/AIDS medications. It functions by regulating the amount of water and minerals in the intestines, which helps to solidify stools and reduce the occurrence of watery diarrhea. This drug should not be used for diarrhea caused by infections. While effective, Mytesi is only available as a brand-name medication, which can make it more costly. Always consult a healthcare professional for advice tailored to your health needs.
Price history for Mytesi
60 Tablet Delayed Releases, 125MG
Average retail price for Mytesi
Average SaveHealth price for Mytesi
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Mytesi dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 125MG | 60 Tablet Delayed Releases | $2,804.46 | $46.74 |
Mytesi FAQs
Mytesi is used to manage diarrhea in adult patients with HIV/AIDS who are on antiretroviral therapy. It helps to improve the quality of life by reducing the frequency and severity of diarrhea associated with this condition.
The generic name for MYTESI is crofelemer.
Mytesi works by inhibiting the secretion of chloride ions and water in the intestines, which helps to reduce the frequency and liquidity of bowel movements. It is primarily used to manage diarrhea in patients with HIV/AIDS who are on antiretroviral therapy.
Mytesi is classified as an antidiarrheal medication. It is specifically used to manage diarrhea in adults with HIV/AIDS who are on antiretroviral therapy.
Mytesi (crofelemer) works by inhibiting the cystic fibrosis transmembrane conductance regulator (CFTR) chloride ion channel and the calcium-activated chloride ion channels at the luminal membrane of enterocytes. This action reduces the secretion of chloride ions and water into the gastrointestinal lumen, thereby decreasing the frequency and volume of diarrhea.